Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in M&A / Deals

Blackstone closes $6.3B fund for life sciences investing

 March 30, 2026

BioPharma Dive

It’s the biggest life sciences private fund ever raised, coming in nearly 40% larger than its Blackstone predecessor vehicle.

M&A / DealsRead full story

Post navigation

Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout →
← S16 Ep40: FDA Approval Insights: Zongertinib for HER2 TKD-Mutated NSCLC: With Julia Rotow, MD; and Martin Dietrich, MD, PhD

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com